A retrospective study assessing changes of subtype's unilateral aldosterone-producing adenoma (APA) and bilateral adrenal hyperplasia (BAH) in patients primary aldosteronism over a 13-year period
Latest Information Update: 11 Nov 2021
At a glance
- Drugs Tetracosactide (Primary)
- Indications Hyperaldosteronism
- Focus Therapeutic Use
- 11 Nov 2021 New trial record
- 01 Nov 2021 Results published in the Journal of Hypertension